EXPERIENCE WITH MICRONIZED PROGESTERONE THERAPY FOR MISCARRIAGE IN PREGNANT WOMEN WITH UTERINE MYOMA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To evaluate the efficiency of the intravaginal route of administration of the natural micronized progesterone prajisun in the therapy of threatened miscarriage in patients with uterine myoma. Subjects and methods. Examinations were made in 64 pregnant women aged 28 to 46 years with uterine myoma and threatened miscarriage at 6-14 weeks’ gestation. There were two groups: 1) 48 women who received the micronized progesterone prajisun intravaginally and 2) 16 had dydrogesterone. All the patients underwent clinical, dynamic ultrasound, and Doppler examinations. Results. The symptoms of threatened miscarriage were abolished and pregnancy preservation was achieved in all the patients of both groups. The pregnant women of the study group had a chance to use the agent at a later time and were satisfied with its intravaginal administration. No side effects were recorded; dynamic vaginal pH measurement demonstrated the maintenance of its readings in the range of 3.5- 4.4. Conclusion. The micronized progesterone prajisun is an effective component of threatened miscarriage therapy for patients with uterine myoma.

Full Text

Restricted Access

About the authors

Alfia Galimovna Iashchuk

Bashkir State Medical University, Ministry of Health of Russia

Email: alfiya_galimovna@mail.ru
MD, professor, Head of Obstetrics and Gynecology Department

Liliana Anasovna Dautova

Bashkir State Medical University, Ministry of Health of Russia

Email: Lili.d5@yandex.ru
Candidate of Medicine, Assoc. Prof. of Obstetrics and Gynecology Department

Yazilya Rashitovna Shevchenko

City Clinical Hospital Eight

Deputy Chief Physician

Raisa Arkadievna Naftulovich

Bashkir State Medical University, Ministry of Health of Russia

Email: raisanaftulovich@mail.ru
PhD. assistant of the Department of Obstetrics and Gynecology № 2

Alla Alexeevna Tyurina

Bashkir State Medical University, Ministry of Health of Russia

Email: tyurina.alla2016@yandex.ru
graduate of the Department of Obstetrics and Gynecology № 2

Vadim Robertovich Murzin

Bashkir State Medical University, Ministry of Health of Russia

Email: pointy_still@mail.ru
resident

References

  1. Буянова С.Н., Логутова Л.С., Щукина Н.А., Мгелиашвили М.В., Юдина Н.В., Гукасян С.А., Ахвледиани К.Н., Чечнева М.А., Ермолаева Е.Е. Миомэктомия вне и во время беременности: показания, особенности хирургической тактики и анестезии, предоперационная подготовка и реабилитация. Российский вестник акушера-гинеколога. 2013; 13(2): 95-100.
  2. Duhan N. Current and emerging treatments for uterine myoma - an update. Int. J. Womems Health. 2011; 3: 231-41.
  3. Рымашевский А.Н., Самсонов А.Е., Терехина Л.А., Юдина Е.Д., Нечаюк В.И. Оптимизация родоразрешения беременных с миомой матки. Российский вестник акушера-гинеколога. 2011; 11(3): 49-51.
  4. Даутова Л.А., Ящук А.Г., Иванова К.Н., Гарипов Д.Р. Прегравидарная подготовка в успешной реализации репродуктивного потенциала. В кн.: Материалы I Общероссийской конференции с международным участием «Перинатальная медицина: от прегравидарной подготовки к здоровому материнству и детству». Санкт-Петербург, 9-11 декабря 2014г. СПб.; 2014.
  5. Гончарова С.В., Башмакова Н.В. Потеря беременности: патогенетическая терапия и ее исходы у женщин группы высокого риска. Вопросы гинекологии, акушерства и перинатологии. 2014; 13(3): 19-26.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies